• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[(99)锝(m)-甲氧基异丁基异腈在原发性甲状旁腺功能亢进症甲状旁腺疾病诊断中的效能]

[Efficiency of (99)Tc(m)-sestamibi in diagnosis of parathyroid diseases with primary hyperparathyroidism].

作者信息

Wei Bojun, Shen Hong, Tong Guansheng, Wang Rengui, Chang Hong

机构信息

Departmen of Otorhinolaryngology Head and Neck Surgery, Beijng Shijitan Hospital, Capital Medical University, Beijing 100038, China. Email:

Departmen of Otorhinolaryngology Head and Neck Surgery, Beijng Shijitan Hospital, Capital Medical University, Beijing 100038, China.

出版信息

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015 Feb;50(2):123-6.

PMID:25916532
Abstract

OBJECTIVE

To evaluate the efficiency of (99)Tc(m)-sestamibi (MIBI) in the diagnosis of parathyroid diseases with primary hyperparathyroidism.

METHODS

One hundred and four cases with primary hyperparathyroidism underwent MIBI and parathyroidectomy between May 2010 to November 2013 were reviewed. With MIBI, single adenoma was found in 91 cases, two adenomas in 5 cases, carcinoma and hyperplasia in 3 cases respectively. Primary hyperparathyroidism was diagnosed based on the associated symptoms and signs in 93 patients, while it was indicated in 11 asymptomatic patients due to the presence of hypercalcemia in health examination. Parathroid hormone levels ranged from 98 to 2 800 ng/L, and serum calcium levels were between 2.56-4.23 mmol/L.

RESULTS

The sensitivity of MIBI for total diseased parntyroids was 84.0% (100/119), and that for parathyroid adenoma, parnthyroid carcinoma, atypical adenoma and primary parathyroid hyperplasia was 87.1% (88/101), 3/3, 2/2 and 7/13, respectively.

CONCLUSIONS

MIBI is efficient in the diagnosis of parathyroid diseases with primary hyperparathyroidism. The size and cystic degeneration of parathroid disease are two common factors decreasing MIBI reliability, and thyroid nodule is additional source leading to false-positive results.

摘要

目的

评估99锝-甲氧基异丁基异腈(MIBI)诊断原发性甲状旁腺功能亢进甲状旁腺疾病的效能。

方法

回顾性分析2010年5月至2013年11月期间104例行MIBI检查并接受甲状旁腺切除术的原发性甲状旁腺功能亢进患者。MIBI检查发现91例为单发性腺瘤,5例为双发性腺瘤,3例分别为癌和增生。93例患者根据相关症状和体征诊断为原发性甲状旁腺功能亢进,11例无症状患者因体检发现高钙血症而被诊断。甲状旁腺激素水平为98~2 800 ng/L,血清钙水平为2.56~4.23 mmol/L。

结果

MIBI对全部病变甲状旁腺的敏感度为84.0%(100/119),对甲状旁腺腺瘤、甲状旁腺癌、非典型腺瘤和原发性甲状旁腺增生的敏感度分别为87.1%(88/101)、3/3、2/2和7/13。

结论

MIBI对诊断原发性甲状旁腺功能亢进甲状旁腺疾病有效。甲状旁腺疾病的大小和囊性变是降低MIBI可靠性的两个常见因素,甲状腺结节是导致假阳性结果的额外原因。

相似文献

1
[Efficiency of (99)Tc(m)-sestamibi in diagnosis of parathyroid diseases with primary hyperparathyroidism].[(99)锝(m)-甲氧基异丁基异腈在原发性甲状旁腺功能亢进症甲状旁腺疾病诊断中的效能]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015 Feb;50(2):123-6.
2
Correlation between serum calcium levels and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy in primary hyperparathyroidism.原发性甲状旁腺功能亢进症患者血清钙水平与双期(99m)Tc-甲氧基异丁基异腈甲状旁腺闪烁扫描术的相关性
Clin Physiol Funct Imaging. 2012 Jan;32(1):19-24. doi: 10.1111/j.1475-097X.2011.01048.x. Epub 2011 Aug 24.
3
Thyroid-related factors that influence preoperative localization of parathyroid adenomas.影响甲状旁腺瘤术前定位的甲状腺相关因素。
Endocr Pract. 2012 Jan-Feb;18(1):26-33. doi: 10.4158/EP11089.OR.
4
Cystic parathyroid adenoma: Primary hyperparathyroidism without Tc-MIBI uptake.囊性甲状旁腺腺瘤:无锝-甲氧基异丁基异腈摄取的原发性甲状旁腺功能亢进症。
Rev Esp Med Nucl Imagen Mol. 2017 Jul-Aug;36(4):254-256. doi: 10.1016/j.remn.2017.01.006. Epub 2017 Apr 6.
5
Diagnostic value of clinical parameters and parathyroid scintigraphy for asymptomatic primary hyperparathyroidism.临床参数和甲状旁腺闪烁显像对无症状原发性甲状旁腺功能亢进症的诊断价值。
Hell J Nucl Med. 2020 May-Aug;23(2):148-157. doi: 10.1967/s002449912104. Epub 2020 Jul 27.
6
Sestamibi scanning and minimally invasive radioguided parathyroidectomy without intraoperative parathyroid hormone measurement.不进行术中甲状旁腺激素测量的锝-99m甲氧基异丁基异腈扫描和微创放射性导向甲状旁腺切除术。
Ann Surg. 2003 May;237(5):722-30; discussion 730-1. doi: 10.1097/01.SLA.0000064362.58751.59.
7
Clinicopathologic and radiopharmacokinetic factors affecting gamma probe-guided parathyroidectomy.影响γ探针引导下甲状旁腺切除术的临床病理和放射药代动力学因素。
Arch Surg. 2004 Nov;139(11):1175-9. doi: 10.1001/archsurg.139.11.1175.
8
The accuracy of 99m Tc-MIBI scintigraphy for preoperative parathyroid localization in primary and secondary-tertiary hyperparathyroidism.99m锝-甲氧基异丁基异腈闪烁扫描术在原发性和继发性-三发性甲状旁腺功能亢进症术前甲状旁腺定位中的准确性。
J Med Assoc Thai. 2012 Mar;95 Suppl 3:S81-91.
9
Minimally invasive surgery for treatment of hyperparathyroidism.用于治疗甲状旁腺功能亢进症的微创手术。
Isr Med Assoc J. 2005 May;7(5):323-7.
10
Minimally invasive radioguided parathyroid surgery using low-dose Tc-99m-MIBI - comparison with standard high dose.使用低剂量锝-99m-甲氧基异丁基异腈的微创放射性引导甲状旁腺手术——与标准高剂量的比较。
Endokrynol Pol. 2017;68(4):398-401. doi: 10.5603/EP.a2017.0031. Epub 2017 May 29.

引用本文的文献

1
Analysis of the successful clinical treatment of 140 patients with parathyroid adenoma: A retrospective study.140例甲状旁腺腺瘤患者临床治疗成功情况分析:一项回顾性研究。
World J Clin Cases. 2022 Oct 6;10(28):10031-10041. doi: 10.12998/wjcc.v10.i28.10031.
2
Diagnosis performance of Tc-MIBI and multimodality imaging for hyperparathyroidism.锝-甲氧基异丁基异腈(Tc-MIBI)及多模态成像对甲状旁腺功能亢进症的诊断性能
J Huazhong Univ Sci Technolog Med Sci. 2017 Aug;37(4):582-586. doi: 10.1007/s11596-017-1776-y. Epub 2017 Aug 8.